TEL AVIV, Israel: Colonoscopy is a test mainly used for early detection of colorectal cancer, the second most lethal cancer in the world. It is considered one of the most expensive preventative screen tests used in the healthcare industry.

The invasive, expensive and uncomfortable test, conducted with devices that have not been significantly-modified for many years could be set to undergo a significant transformation. Beersheva-based Consis Medical hopes to replace traditional colonoscopes with its single-use endoscopes that are safer and significantly cheaper to use. A prototype of the Israeli company’s colonoscopies is currently being tested on human colon simulators and animals.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details